Lippincott ® NursingCenter ® Wolters Kluwer Logo

Buprenorphine Extended-Release Injection for Subcutaneous Use (Brixadi): A Novel Option for the Treatment of Opioid Use Disorder

Source:

Journal of Addictions Nursing

July/September 2025, Volume :36 Number 3 , page 230 - 232 [Buy]

Go to article

Authors

  1. Kameg , Brayden

FIND YOUR NEXT JOB WITH NURSING JOBSPLUS

CE Resources

Nursing Resources

About NursingCenter

 

© 2025 Wolters Kluwer Health, Inc. and/or its subsidiaries. All rights reserved. – Terms & Conditions – Privacy Policy – Disclaimer – Your California Privacy Choices -- v10.07.00